Androgen receptor blockade promotes response to BRAF/MEK-targeted therapy
2022 · Nature · 129 citations
https://doi.org/10.1038/s41586-022-04833-8
E
Eleonora Pagan
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
95
Papers
2.1K
Citations
22
h-index
35
i10-index
Eleonora Pagan is an academic researcher from University of Milano-Bicocca. The author has contributed to research in topics: Breast Cancer Treatment Studies & Breast Lesions and Carcinomas & Immune Cell Function and Interaction. The author has an h-index of 22, co-authored 81 publications.
ORCID: 0000-0002-6788-394XPapers by this author
worksSex-based differences in response to anti-PD-1 or PD-L1 treatment in patients with non-small-cell lung cancer expressing high PD-L1 levels. A systematic review and meta-analysis of randomized clinical trials
2021 · ESMO Open · 79 citations
https://doi.org/10.1016/j.esmoop.2021.100251
Biological and clinical features of triple negative Invasive Lobular Carcinomas of the breast. Clinical outcome and actionable molecular alterations
2021 · The Breast · 20 citations
https://doi.org/10.1016/j.breast.2021.06.011
Prognosis of selected triple negative apocrine breast cancer patients who did not receive adjuvant chemotherapy
2020 · The Breast · 15 citations
https://doi.org/10.1016/j.breast.2020.07.003
Different Response to Immunotherapy According to Melanoma Histologic Subtype
2021 · Journal of Immunotherapy · 8 citations
https://doi.org/10.1097/cji.0000000000000403
Reply to Comments on: “Preventing chemotherapy-induced alopecia: a prospective clinical trial on the efficacy and safety of a scalp cooling system in early breast cancer patients treated with anthracyclines.”
2019 · British Journal of Cancer · 6 citations
https://doi.org/10.1038/s41416-019-0577-4
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat